1. Home
  2. Analysis
  3. Eliquis
  4. Timoptic

Eliquis and Timoptic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eliquis (apixaban) and Timoptic (timolol maleate). Common drug interactions include groin pain among females and decreased appetite among males.

The phase IV clinical study analyzes what interactions people have when they take Eliquis and Timoptic. It is created by eHealthMe based on reports of 46 people who take the same drugs from the FDA, and is updated regularly.

What is Eliquis?

Eliquis has active ingredients of apixaban. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 191,861 Eliquis users. Check the latest studies of Eliquis.

What is Timoptic?

Timoptic has active ingredients of timolol maleate. It is often used in glaucoma. eHealthMe is studying from 4,247 Timoptic users. Check the latest studies of Timoptic.

On Jul, 31, 2026

46 people who take Eliquis and Timoptic together, and have interactions are studied.

Eliquis and Timoptic drug interactions.

What are the common drug interactions of Eliquis and Timoptic, by gender? *:

female:

  1. Groin pain
  2. Head injury
  3. Hepatic enzyme increased
  4. Immobile (not moving)
  5. Infection
  6. Inflammation
  7. Infusion related reaction
  8. Injection site rash
  9. Joint abscess (pus in joints due to infection)
  10. Joint destruction (joint damage)

male:

  1. Decreased appetite
  2. Diarrhoea
  3. Mitral valve incompetence (inefficient heart valve)
  4. Osteoporosis (bones weak and more likely to break)
  5. Pneumonia
  6. Weight decreased
  7. Abdominal distension
  8. Asthenia (weakness)
  9. Blood pressure increased
  10. Chest pain

What are the common drug interactions of Eliquis and Timoptic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Fall
  2. Decreased appetite
  3. Colitis ulcerative (inflammation of colon with ulcer)
  4. Pelvic fracture
  5. Blood pressure increased
  6. Aortic valve incompetence
  7. Bleeding varicose vein
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Dyspnoea (difficult or laboured respiration)
  10. Fatigue (feeling of tiredness)

What are the existing conditions these people have? *

  1. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 7 people, 15.22%
  2. Prostate Cancer: 5 people, 10.87%
  3. Multiple Myeloma (cancer of the plasma cells): 5 people, 10.87%
  4. Immunodeficiency Common Variable: 4 people, 8.70%
  5. High Blood Pressure: 4 people, 8.70%
  6. Pain: 3 people, 6.52%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 3 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Eliquis and Timoptic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Eliquis and Timoptic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Eliquis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Timoptic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Eliquis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Timoptic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on apixaban and timolol maleate (the active ingredients of Eliquis and Timoptic, respectively), and Eliquis and Timoptic (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.